Effects of different antimicrobial treatments on serum acute phase responses and leucocyte counts in pigs after a primary and a secondary challenge infection with Actinobacillus pleuropneumoniae.

The susceptibility to an initial challenge and a re-challenge inoculation with Actinobacillus pleuropneumoniae was analysed in pigs that were treated with antimicrobials of different efficacies following the first exposure to A pleuropneumoniae. In brief, 30 nine-week-old specific pathogen-free pigs were allocated to five groups of six. After acclimatisation, four groups were inoculated with A pleuropneumoniae serotype 2. At the onset of clinical signs, three of the groups of pigs were treated with enrofloxacin, tetracycline or penicillin. A fourth group served as the inoculated control and the fifth group as a control group that had not been inoculated. On day 28, all five groups were re-challenged with the same strain of A pleuropneumoniae serotype 2 as had been used in the first inoculation. No treatments were carried out at this time. The acute phase responses and differential leucocyte counts were monitored in detail after both inoculations. Leucocytosis and acute phase responses in the forms of serum amyloid A, pig-major acute phase protein and haptoglobin were recorded in all of the inoculated groups after the onset of clinical signs following the first inoculation. A porcine mannan-binding lectin-A response was less evident in the pigs. Acute phase responses resembling those of the first inoculation were observed in the pigs that had not previously been inoculated and in the pigs treated with enrofloxacin. Acute phase responses were not recorded in the other three groups, where the pigs had seroconverted to A pleuropneumoniae serotype 2 following the first inoculation.

Acute-phase protein response in pigs experimentally infected with Haemophilus parasuis.

The acute-phase protein (APP) response to an infection caused by Haemophilus parasuis, the etiological agent of Glässer's disease in pigs, was characterized measuring serum concentrations of pig major acute-phase protein (pig MAP), haptoglobin (HPT), C-reactive protein (CRP) and apolipoprotein A-I (ApoA-I) in colostrum-deprived pigs. They were divided into six experimental groups: non-immunized control group (I); immunized with a non-commercial bacterin (II); with an OMP-vaccine (III); with a sublethal dose (IV); and with two commercial bacterins (V and VI). All groups were challenged intratracheally with 5 × 10(9)CFU of H. parasuis 37 days after immunisation. The highest levels of the positive APPs (pig MAP, HPT and CRP) and the lowest levels of the negative APPs (ApoA-I) were observed in the animals that died as a consequence of the infection, both those in the non-immunized and in the immunized groups. However, the surviving animals (all of them in groups II, V and VI, two pigs in group III, and three in group IV) showed a minor variation in APP response, mainly on day 1 post-challenge (p.c.), and then tended to recover the initial values. APP response was still less pronounced in the groups of pigs previously immunized with bacterins. In conclusion, APP response can reflect Glässer-disease ongoing, showing a correlation between the severity and duration of the clinical signs and lesions and the magnitude of changes in the APP levels.

Effect of different vaccine formulations on the development of Glässer's disease induced in pigs by experimental Haemophilus parasuis infection.

Four groups of pigs immunized with different vaccines and a group of non-vaccinated controls were challenged intratracheally with a lethal dose (5 x 10(9) colony-forming units) of Haemophilus parasuis, the aetiological agent of Glässer's disease. A vaccine containing inactivated whole organisms gave strong protection against clinical signs, death, pathological changes and persistence of organisms in vivo. However, all non-immunized pigs, all pigs given a vaccine consisting of the recombinant transferring-binding protein (Tbp) B, some pigs given an outer membrane protein (OMP) formulation enriched with TbpB and some pigs immunized with a sub-lethal dose of live organisms died at various times after challenge, yielding positive cultures from most organs post mortem and having shown hyperthermia and other clinical signs before death. Animals that died showed fibrinosuppurative polyserositis, exudative pneumonia, and lesions compatible with acute septicaemia, e.g., disseminated intravascular coagulation with multiple fibrinous thrombi in arterioles and capillaries, depletion of splenic white pulp, and acute lymphadenitis. The results suggested that, in addition to the protection given by inactivated whole organisms, partial protection was given by the OMP formulation and by a sub-lethal dose of living organisms; however, the recombinant TbpB preparation gave no protection.

Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.

The serum antibody response to an experimental infection by Haemophilus parasuis, the etiological agent of Glässer's disease in pigs, was characterized by ELISA measuring IgM and IgGt levels against whole-cells and outer-membrane-proteins (OMPs) as antigens. Five groups of pigs were studied, four of those were previously immunized with different formulations, and the fifth was maintained as non-immunized control. All groups were challenged with 5x10(9) CFU of H. parasuis. The non-commercial bacterin induced a full protection against disease, the OMP-vaccine and the exposure to a sublethal dose of 10(5) CFU protected only partially, and the recombinant TbpB-vaccine conferred no protection. The humoral response in the pigs that died after infection (all controls, all those vaccinated with the recombinant TbpB, and two of both those inoculated with OMPs and those exposed to the sublethal dose) could be only measured before it, but it was irrelevant in all cases. However, a specific IgM and IgGt production was observed before challenge in all the surviving pigs, irrespective of the type of immunization received. This antibody response was even greater after H. parasuis infection, especially in those survivors receiving the sublethal dose. These results suggest a role of the antibodies developed after the different immunization protocols in preventing infection and death; therefore, the humoral immunity is protective against experimental Glässer's disease.

Aplicación clínica de los principios farmacocinéticos y farmacodinámicos en anestesia total intravenosa / No disponible

Para obtener una anestesia adecuada, reduciendo el riesgo de toxicidad farmacológica sin comprometer la eficacia, es necesario conocer la evolución temporal de las concentraciones del fármaco en el organismo (farmacocinética), así como la relación que existe entre esta y el efecto (farmacodinamia). Los conceptos farmacocinéticos y farmacodinámicos son la base para la aplicación de los sistemas de infusión utilizados ampliamente en anestesia intravenosa. Es necesario comprender algunos de estos conceptos para poder entender como funcionan los sistemas de infusión abiertos (TCI), como cerrados (sistemas de asa cerrada). Este trabajo pretende explicar brevemente algunos de estos conceptos, como son la teoría de los modelos compartimentales, el concepto de vida media dependiente del contexto, Keo o la ventana terapéutica, que posteriormente se desarrollan en la descripción del funcionamiento de estos sistemas

To obtain an appropriate anesthesia, reducing the risk of pharmacologic toxicity without affecting efficacy, it is necessary to know the chronological evolution of the drug concentrations in the organism (pharmacokinetics) and the relation between this one and the effect (pharmacodynamics). The pharmacokinetic and pharmacodynamic concepts are the basis for applicating the infusion systems widely used in intravenous anesthesia. It is essential to know some of these ideas to be able to comprehend how these infusion systems work, both open systems (TCI) and closed systems (closed loop systems) This article tries briefly to explain some of these concepts, like compartimental model theory, Context Sensitive Half Life, Keo and therapeutic window. These notions will be explained further in the description of the working of these systems

Anestesia a una paciencia con insuficiencia cardíaca congestiva por hiperaflujo por fístula arteriovenosa renal / Anesthesia for a patient with congestive heart failure due to high flow through a renal arteriovenous fistula

No disponible